Molecular Devices Introduces the IMAP(R) Substrate Finder
March 29 2004 - 5:03PM
PR Newswire (US)
Molecular Devices Introduces the IMAP(R) Substrate Finder
SUNNYVALE, Calif., March 29 /PRNewswire-FirstCall/ -- Molecular
Devices Corporation , a leader in innovative solutions for drug
discovery and life sciences research, today announced the launch of
the latest addition to its IMAP Platform, the IMAP Substrate
Finder. The IMAP Platform provides advanced tools for successful
assay development and high throughput screening (HTS) of kinases,
one of the most important target classes in drug discovery today,
as well as for phosphatases and phosphodiesterases. Assay
development is the major roadblock to HTS, and one of the largest
barriers to developing an assay for a novel kinase target is
finding a suitable substrate. The IMAP Substrate Finder accelerates
the difficult task of finding new substrates for these unique or
proprietary kinases. The IMAP Substrate Finder provides a quick,
sensitive, yet inexpensive method to screen dozens of substrates
for new kinases in a couple of hours. Molecular Devices' IMAP
technology is rapidly becoming the established assay format to
screen kinase activity because it can be used in all regions of the
human kinome. The IMAP Binding Systems and the IMAP Substrate
Finder enable the end user to quickly develop assays for uncommon
or proprietary enzymes with the same ease of miniaturization and
low cost-per-well researchers have come to expect when using IMAP.
Molecular Devices also offers twenty-three specific IMAP kits that
provide a turnkey solution to evaluate and test the flexibility of
the IMAP Platform and smoothly transition into high-throughput
screening. "Phosphatases and kinases are important drug targets
that are screened at all major pharmaceutical companies. With the
IMAP Substrate Finder, the length of time spent in assay
development is reduced dramatically, allowing companies to realize
cost-savings and increased productivity in their drug discovery
process," stated Stephen J. Oldfield, Ph.D. and Vice President of
Worldwide Marketing atMolecular Devices. "And we believe that our
proprietary IMAP technology, with its ease of use, stable signal
and inherent flexibility, is ideal for the rigorous demands of
high-throughput screening." Molecular Devices Corporation is a
leading supplierof high-performance bioanalytical measurement
systems that accelerate and improve drug discovery and other life
sciences research. The Company's systems and consumables enable
pharmaceutical and biotechnology companies to leverage advances in
genomics, proteomics and combinatorial chemistry by facilitating
the high-throughput and cost-effective identification and
evaluation of drug candidates. The Company's solutions are based on
its advanced core technologies that integrate its expertise in
engineering, molecular and cell biology and chemistry. Molecular
Devices enables its customers to improve research productivity and
effectiveness, which ultimately accelerates the complex process of
discovering and developing new drugs. This press release contains
"forward-looking" statements, including statements related to the
prospects for or potential customer use of the IMAP Platform and
IMAP Substrate Finder. Any statements contained in this press
release that are not statements of historical fact may be deemed to
be forward-looking statements. Words such as "believes,"
"anticipates," "plans," "expects," "will," and similar expressions
are intended to identify forward-looking statements. There are a
number of important factors that could cause theresults of
Molecular Devices Corporation to differ materially from those
indicated by these forward-looking statements, including, among
others, risks detailed from time to time in the Company's SEC
reports, including its Annual Report on Form 10-K for the year
ended December 31, 2003. Molecular Devices Corporation does not
undertake any obligation to update forward-looking statements.
DATASOURCE: Molecular Devices Corporation CONTACT: Tim Harkness of
Molecular Devices Corporation, +1-408-747-3533 Web site:
http://www.moleculardevices.com/
Copyright
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Molecular Devices (NASDAQ:MDCC)
Historical Stock Chart
From Jul 2023 to Jul 2024